Role of bone marrow-derived mesenchymal stem cells in a rat model of severe acute pancreatitis

Table 6 Comparison of intestinal mucosa injury scores (each slice/score) and proliferating cells of small intestinal mucosa (each slice/number) determined at various time points after injecting either mesenchymal stem cells or saline after establishment of an severe acute pancreatitis model (n = 36, mean ± SD)

Group	Post-MSCs or saline injection (h)
	6		24		72
	Intestinal mucosa injury scores	proliferating cells number	Intestinal mucosa injury scores	proliferating cells number	Intestinal mucosa injury scores	proliferating cells number
SAP group	43.33 ± 4.84	39.50 ± 5.09	52.83 ± 5.27	59.67 ± 6.80	32.17 ± 4.17	81.50 ± 7.89
SAP + MSCs group	36.33 ± 5.72a	40.83 ± 5.12	46.33 ± 2.80a	68.00 ± 3.22a	26.67 ± 3.08a	101.00 ± 11.58b

^aP < 0.05,

^bP < 0.01 vs the severe acute pancreatitis (SAP) group. MSCs: Mesenchymal stem cells.